The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Estimated Growth In Market Size Of The Lab Automation In Drug Discovery Market During 2026–2030?
The lab automation in drug discovery market size has shown significant expansion in recent years. It is anticipated to grow from $6.77 billion in 2025 to $7.12 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.1%. The growth observed in previous periods is largely due to factors such as the adoption of robotic arms in laboratories, increased investment in pharmaceutical research and development, a heightened demand for automation to reduce errors, the integration of lab information management systems, and the progression of high-throughput screening technologies.
The lab automation in drug discovery market is anticipated to experience strong growth in the coming years. It is projected to reach $8.72 billion in 2030, with a compound annual growth rate (CAGR) of 5.2%. This growth in the forecast period is attributed to the expansion of AI-driven drug discovery platforms, the increasing demand for personalized medicine, the development of cloud-based lab management solutions, the adoption of advanced robotics for sample handling, and rising collaborations between pharma and biotech companies. Key trends in the forecast period include high-throughput screening automation, integrated laboratory workflows, predictive analytics in drug discovery, miniaturization of lab processes, and cloud-based lab management.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp
Which Drivers Are Advancing The Lab Automation In Drug Discovery Market Growth?
Growing requirements for precision medicine are projected to boost the expansion of lab automation within the drug discovery market moving ahead. Precision medicine, interchangeably referred to as personalized medicine, represents a medical treatment and prevention strategy that considers each person’s unique variations in genes, environment, and lifestyle. Lab automation speeds up research, enhances the reproducibility of experiments, and boosts the efficiency of procedures in precision medicine and drug discovery, which ultimately results in the development of more effective medications and diagnostic tools tailored for individual patients. For example, the US-based non-profit organization, Personalized Medicine Coalition, disclosed in February 2024 that the FDA had sanctioned 16 novel personalized treatments for rare disease patients in 2023, marking a considerable rise from the six approved in 2022. Consequently, the rising need for precision medicine is fueling the expansion of lab automation in the drug discovery market.
How Is The Lab Automation In Drug Discovery Market Distributed Across Key Segments?
The lab automation in drug discovery market covered in this report is segmented –
1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Component: Instruments, Software, Services
3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users
Subsegments:
1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations
2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems
3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots
4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems
5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems
Which Trends Are Expected To Shape The Lab Automation In Drug Discovery Market?
Leading companies engaged in the lab automation segment within the drug discovery market are prioritizing the integration of AI-driven and robotics-based platforms to expedite formulation development and elevate R&D efficiency. These AI-powered and robot-assisted platforms employ intelligent algorithms and automated machines to streamline operations, enhance precision, and accelerate workflows. For example, in May 2025, Intrepid Labs, a Canada-based research laboratory, launched its Valiant platform, which is an AI-driven and robotics-enabled system designed to significantly speed up drug formulation development. With over $11 million in total funding, including a recent $7 million seed round led by AVANT BIO, the company aims to replace slow, trial-and-error formulation processes with rapid, data-driven optimization. Valiant autonomously explores entire formulation design spaces, cutting timelines from months to days while simultaneously boosting therapeutic performance and safety. Since its founding in 2023, Intrepid Labs has established partnerships with key pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.
Which Key Players Are Active In The Lab Automation In Drug Discovery Market?
Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation
Access The Complete Lab Automation In Drug Discovery Market Report:
Which Region Contributes The Most To The Lab Automation In Drug Discovery Market?
North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Lab Automation In Drug Discovery Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp
Browse Through More Reports Similar to the Global Lab Automation In Drug Discovery Market 2026, By The Business Research Company
Lab Automation In Drug Discovery Market Report 2026
Lab Automation In Genomics Market Report 2026
https://www.thebusinessresearchcompany.com/report/lab-automation-in-genomics-global-market-report
Lab Automation Market Report 2026
https://www.thebusinessresearchcompany.com/report/lab-automation-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model